A recent case of an elderly male patient with melanoma receiving combination nivolumab and ipilimumab, presented with abdominal pain, diarrhea and generalized edema, positive serology for tTG-IgA, endoscopy suggestive of duodenal mucosal atrophy with duodenal biopsies confirming fulminant celiac disease. This evidence concerns the gene CD79A and celiac disease.